The European Medicines Agency's strategies to meet the challenges of Alzheimer disease

被引：11

作者：

Haas, Manuel ^{[1
]}

Mantua, Valentina ^{[2
]}

Haberkamp, Marion ^{[3
]}

Pani, Luca ^{[2
]}

Isaac, Maria ^{[1
]}

Butlen-Ducuing, Florence ^{[1
]}

Vamvakas, Spiros ^{[1
]}

Broich, Karl ^{[3
]}

机构：

[1] European Meds Agcy, London E14 5EU, England

[2] Agenzia Italiana Farmaco, I-00187 Rome, Italy

[3] Bundesinstitut Arzneimittel & Medizinprodukte, D-53175 Bonn, Germany

来源：

NATURE REVIEWS DRUG DISCOVERY | 2015年 / 14卷 / 04期

关键词：

D O I：

10.1038/nrd4585

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we highlight the strategies of the European Medicines Agency to help address such challenges.

引用

页码：221 / 222

页数：2

共 50 条

[1] The European Medicines Agency's strategies to meet the challenges of Alzheimer disease
Manuel Haas
Valentina Mantua
Marion Haberkamp
Luca Pani
Maria Isaac
Florence Butlen-Ducuing
Spiros Vamvakas
Karl Broich
Nature Reviews Drug Discovery, 2015, 14 : 221 - 222
[2] The European Medicines Agency rejects the authorization of aducanumab for Alzheimer's disease
Dal-Re, Rafael
REVISTA DE NEUROLOGIA, 2022, 74 (06) : 207 - 208
[3] THE EUROPEAN MEDICINES AGENCY'S STRATEGIES TO TACKLE THE CHALLENGES OF AD DRUG DEVELOPMENT
Mantua, Valentina
NEUROBIOLOGY OF AGING, 2016, 39 : S6 - S6
[4] For the European Medicines Agency, a decade of challenges
Rice, M
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) : 1403 - 1405
[5] European Medicines Agency
Camarero, J.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S38 - S39
[6] Comparing online campaigning strategies to host the European Medicines Agency
Tunon-Navarro, Jorge
Catalan-Matamoros, Daniel
PROFESIONAL DE LA INFORMACION, 2020, 29 (02):
[7] Should the European Medicines Agency consider ageing a disease?
Penella, Guillermo Marin
BIOETHICS, 2024, 38 (05) : 431 - 437
[8] THE EUROPEAN MEDICINES AGENCY: A PUBLIC HEALTH EUROPEAN AGENCY?
Mahalatchimy, Aurelie
Rial-Sebbag, Emmanuelle
De Grove-Valdeyron, Nathalie
Tournay, Virginie
Cambon-Thomsen, Anne
Duguet, Anne-Marie
Taboulet, Florence
MEDICINE AND LAW, 2012, 31 (01): : 25 - 42
[9] Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges
Han, Ying
Liu, Daozhou
Cheng, Ying
Ji, Qifeng
Liu, Miao
Zhang, Bangle
Zhou, Siyuan
REDOX BIOLOGY, 2023, 63
[10] Challenges for participatory research strategies and approaches in Alzheimer's disease
Naue, Ursula
Kroll, Thilo
DISABILITY AND HEALTH JOURNAL, 2009, 2 (01) : E4 - E4

← 1 2 3 4 5 →